InsideArbitrage Event Driven Monitor – February 3, 2023

Quick updates on the event driven strategies we follow on InsideArbitrage.

Merger Arbitrage

1. Sun Pharmaceutical Industries Limited launched its tender offer for Concert Pharmaceuticals (CNCE). The tender offer will expire on March 3, 2023.
2. The UK’s Competition and Markets Authority is expected to release its findings on the purchase of Activision Blizzard (ATVI) by Microsoft Corporation (MSFT) in a week’s time.
3. Atlas Corp. (ATCO) received regulatory confirmation for its transaction with Poseidon Acquisition Corp., from Brazil’s Administrative Council for Economic Defence, Turkey’s Competition Authority and Australia’s Competition and Consumer Commission.

Only plus or premium subscribers can access this post. Subscribe today.